Lake Street analyst Max Michaelis lowered the firm's price target on Knightscope to $8 from $9 and keeps a Buy rating on the shares. Revenue came in below the firm's expectations, but AEBITDA came in slightly ahead, the analyst tells investors. The firm lowered estimates in both 2025 and 2026 to account for the slower deployment of ASRs and ECD supply disruptions, the analyst noted. However, while the results were "disappointing," the firm believes the Knightscope "story is more about the long-term growth opportunities versus the quarterly print," the analyst added.
